Want to join the conversation?
$BNED expects FY17 total sales growth of 2-4%, while comparable store sales are expected to be about flat to 2.0% lower than the prior year. $BNED now plans to open 32 new stores in FY17, with estimated annual sales of about $110MM. $BNED sees Adjusted EBITDA growth of about 12%, and capital expenditures of about $50MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.